|
WO2021015625A1
|
|
Iud insertion device
|
|
WO2020226513A1
|
|
Novel ligand assays
|
|
US10763966B1
|
|
Data communications system using an optical antenna
|
|
WO2019125185A1
|
|
Quinoline sulfonamide compounds and their use as antibacterial agents
|
|
US2020289453A1
|
|
Pharmaceutical Combinations and Methods for the Treatment of Diabetes and Associated Disorders
|
|
AU2018361865A1
|
|
Test kits and assays
|
|
WO2018217104A1
|
|
Glass ionomer cement containing silver nanoparticles
|
|
CN109451722A
|
|
The processing of biomaterial containing keratin
|
|
KR20180089474A
|
|
Photo-activated preparation of hydrogel
|
|
CN110914240A
|
|
Norbornene ketone compounds releasing carbon monoxide
|
|
US2019000759A1
|
|
Antimicrobial gel containing silver nanoparticles
|
|
EP3069146A1
|
|
Biomarker for cardiac disorders
|
|
AU2014281270A1
|
|
Assay for Anti-Mullerian Hormone
|
|
WO2014137228A1
|
|
Reaction vessel holder and molecule detection device
|
|
EP2948126A1
|
|
Assembly of micelle aggregates of surfactant micelles and silver nanoparticles and use as antibacterial agent
|
|
CN104937420A
|
|
NT-proCNP as a biomarker of vascular disorders and pregnancy complication
|
|
AU2013263502A1
|
|
Combination treatments and compositions for wound healing
|
|
CN104470942A
|
|
Biomarkers
|
|
SG11201400067TA
|
|
Cardiovascular therapeutics
|
|
NZ605640A
|
|
Signal biomarkers
|
